Exogenous ketones as a metabolic intervention for Parkinson’s disease

Exogenous ketones as a metabolic intervention for Parkinson’s disease

<p>Neurodegenerative and neurological diseases are metabolic diseases that invite metabolic treatments. Nutritional interventions that induce a state of ketosis, or “ketogenics,” are one class of metabolic treatment that have the potential to address the root pathologies of such diseases. Pr...

書誌詳細
第一著者:	Norwitz, N
その他の著者:	Clarke, K
フォーマット:	学位論文
言語:	English
出版事項:	2020
主題:	Metabolism Neurodegenerative diseases

類似資料

Metabolism of exogenous ketones
著者:: Stubbs, B
出版事項: (2016)

Insights into Lipid Metabolism and Composition in Parkinson’s Disease Pathogenesis
著者:: Pei Xiaoxue, 等
出版事項: (2024-11-01)

Degeneration of dopaminergic neurons due to metabolic alterations and Parkinson’s disease
著者:: Juhyun eSong, 等
出版事項: (2016-03-01)

Targeting Glucose Metabolism: A Novel Therapeutic Approach for Parkinson’s Disease
著者:: Ahmed Tanvir, 等
出版事項: (2024-11-01)

Altered substrate metabolism in neurodegenerative disease: new insights from metabolic imaging
著者:: Nicholas R. W. Cleland, 等
出版事項: (2021-10-01)

The Importance of Gut Microbiota on Choline Metabolism in Neurodegenerative Diseases
著者:: Majid Eslami, 等
出版事項: (2024-10-01)

Targeting cardiolipin metabolism for Parkinson's disease therapy
著者:: Junli Liu, 等
出版事項: (2024-12-01)

Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?
著者:: Theodora Mourtzi, 等
出版事項: (2022-01-01)

Review of Current Human Genome-Scale Metabolic Models for Brain Cancer and Neurodegenerative Diseases
著者:: Ali Kishk, 等
出版事項: (2022-08-01)

Ghrelin: A link between ageing, metabolism and neurodegenerative disorders
著者:: I.I. Stoyanova
出版事項: (2014-12-01)

Effect of a physical therapeutic intervention on locomotive syndrome in the elderly patients with Parkinson’s disease and sarcopenia
著者:: Ivanna V. Didoha, 等
出版事項: (2023-03-01)

OPA1 deficiency impairs oxidative metabolism in cycling cells, underlining a translational approach for degenerative diseases
著者:: Aurélie M. C. Millet, 等
出版事項: (2023-09-01)

Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
著者:: Paulo J. da Costa, 等
出版事項: (2022-01-01)

Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism
著者:: Alessio Canovai, 等
出版事項: (2025-01-01)

On the Metabolism of Exogenous Ketones in Humans
著者:: Stubbs, B, 等
出版事項: (2017)

On the Metabolism of Exogenous Ketones in Humans
著者:: Brianna J. Stubbs, 等
出版事項: (2017-10-01)

A Ketone Ester Drink Enhances Endurance Exercise Performance in Parkinson’s Disease
著者:: Nicholas G. Norwitz, 等
出版事項: (2020-09-01)

Role of metabolic characteristics in the co-occurrence of insomnia, Alzheimer’s disease, and Parkinson’s disease: a Mendelian randomization study
著者:: Chengyong Liu, 等
出版事項: (2025-01-01)

Mitochondrial Dysfunction in Parkinson’s Disease—Cause or Consequence?
著者:: Chun Chen, 等
出版事項: (2019-05-01)

Exogenous ketone therapy for heart failure: A review
著者:: Yulia O. Aksenova, 等
出版事項: (2023-05-01)

The role of the gut microbiota in neurodegenerative diseases targeting metabolism
著者:: Yufeng Fu, 等
出版事項: (2024-09-01)

Secretome as neuropathology-targeted intervention of Parkinson’s disease
著者:: Christian Ardianto, 等
出版事項: (2022-12-01)

The Metabolism of Coenzyme A and Its Derivatives Plays a Crucial Role in Diseases
著者:: Jumin Xie, 等
出版事項: (2024-04-01)

Ketone metabolism in the heart
著者:: Bin abdul kadir, A
出版事項: (2020)

The genetic basis of Parkinson's disease
著者:: A. A. Tappakhov, 等
出版事項: (2017-03-01)

The importance of using methods of selective modification of neuronal function in the pathogenesis and therapy of Parkinson's disease
著者:: Maciej Superson, 等
出版事項: (2024-07-01)

No association between adult height and Parkinson's disease
著者:: Younggee Jeong, 等
出版事項: (2023-01-01)

Impact of tango on Parkinson's disease - a narrative review
著者:: Magdalena Muzyk, 等
出版事項: (2024-08-01)

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
著者:: Hayder M. Al‐kuraishy, 等
出版事項: (2023-04-01)

Meaning in life and Parkinson’s disease in the UK Biobank
著者:: Angelina R. Sutin, 等
出版事項: (2024-01-01)

Alpha-Synuclein spreading in Parkinson disease
著者:: Ariadna eRecasens, 等
出版事項: (2014-12-01)

Alternative cleavage and polyadenylation of genes associated with protein turnover and mitochondrial function are deregulated in Parkinson’s, Alzheimer’s and ALS disease
著者:: Radhika Patel, 等
出版事項: (2019-05-01)

OX40 Gene and Serum Protein Expression Profiles in Patients with Parkinson’s Disease
著者:: Azadeh Seyedjoodaki, 等
出版事項: (2018-04-01)

Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson’s Disease
著者:: Srinivasa Reddy Bonam, 等
出版事項: (2021-12-01)

The diagnostic reliability of outpatient neurological care to patients with Parkinson’s disease
著者:: Voskresenskaya O.N., 等
出版事項: (2012-06-01)

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease
著者:: Song Li, 等
出版事項: (2022-04-01)

The emerging role of disease-associated microglia in Parkinson’s disease
著者:: Ritika R. Samant, 等
出版事項: (2024-11-01)

Active Immunotherapy for the Prevention of Alzheimer’s and Parkinson’s Disease
著者:: Madeline M. Vroom, 等
出版事項: (2024-08-01)

Anti-Oxidant and Tyrosinase Inhibitory In Vitro Activity of Amino Acids and Small Peptides: New Hints for the Multifaceted Treatment of Neurologic and Metabolic Disfunctions
著者:: Grazia Luisi, 等
出版事項: (2018-12-01)

Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
著者:: Berenice A. Gutierrez, 等
出版事項: (2022-07-01)